Back to medical news
MedPage Today
What's Next for Chronic Hives? New Targets Expand the Treatment Landscape.
October 8, 2026
Original source summary
(MedPage Today) -- New and emerging therapies for chronic spontaneous urticaria (CSU) were a major focus at the American Academy of Dermatology (AAD) meeting, with advances spanning interleukin (IL)-4 receptor blockade, Bruton's tyrosine kinase...
Verbatim from MedPage Today's own feed — "What's Next for Chronic Hives? New Targets Expand the Treatment Landscape."
Want more like this?
Browse more from the feed. A free account unlocks the full feed, saving and communities.
More medical news